Novartis DRC Brolucizumab post-marketing imaging project
Research Grant
Administered By
Ophthalmology
Awarded By
Novartis Pharma AG
Start Date
August 4, 2020
End Date
August 31, 2022
Administered By
Ophthalmology
Awarded By
Novartis Pharma AG
Start Date
August 4, 2020
End Date
August 31, 2022